Actress admitted to hospital after losing weight with Ozempic: “I felt like I was going to die”

cuban actress Lisandra SilvaThe 37-year-old reported on Instagram that he was rushed to the hospital after taking medication. Ozempic Trying to lose weight. Medical organizations have already warned against the use of the drug, which was developed to treat uncontrolled type 2 diabetes but is used indiscriminately for weight loss.. Lysandra spoke about the incident last Friday the 1st.

o per esta reached out to Novo Nordisk, the pharmaceutical company responsible for Ozempic, for comment on the actress’s publication but has not yet received a response. The space remains open.

In a lengthy post on social networks, Lisandra said her doctor recommended the medication. But her blood sugar levels dropped and she had to be admitted to the hospital.

“I had to call their father because I felt like I was going to pass out and they were sleeping next to me,” he said. “Thank you God. “Nothing happened, but I felt like I was going to die, so I got to the hospital in a wheelchair.”

The actress said her “Ozempic” is “Ayurveda diet, meditation and exercise in nature.” “Discipline, determination, mental toughness and clear goals. Health of mind, body and mind. Please take my advice. There is nothing better than a healthy lifestyle. “Don’t make it up,” he asked his followers.

Doctors warn against using Ozempic for weight loss.

Last year, the Brazilian Association for the Study of Obesity (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM) published a joint report on drug use with “Guidelines for the population.” The medical community made clear in its statement that obesity is a complex disease that is chronic, complex, and difficult to treat. Therefore, no medication should be used without prescription and medical supervision.

Ozempic is the brand name of a drug whose active ingredient is semaglutide. According to Novo Nordisk, the drug is used to treat adult patients with type 2 diabetes (where blood sugar levels remain too high) that are unsatisfactorily controlled with diet and exercise. Read the full story:

“-Anvisa-approved obesity drugs should not be criticized as they have proven efficacy and safety. Rather, they are individually selected through medical consultation and sold only on medical prescription. It is the prescribing physician’s role to monitor the patient and periodically re-evaluate effectiveness. Tolerability and safety.

– Misuse, aesthetic and inappropriate use of anti-obesity drugs, in addition to exposing people to risks without indications for use, further adds to the stigma of treatment for people who already suffer from various prejudices in our society. These stigma-exacerbating issues can cause people to forgo successful treatment or not seek medical help.

– As an appendix, ABESO and SBEM are working with public authorities to reduce stigma against obesity treatments (whether pharmaceutical or not) or to ensure that treatment options are accessible to the majority of the population or available through SUS, but this is not yet a reality. no.”

The statement was signed by ABESO President Bruno Halpern and SBEM President Paulo Augusto Carvalho Miranda.